The therapeutic dilemma of idiopathic granulomatous mastitis.
10.47102/annals-acadmedsg.2020645
- Author:
Ee Ling Serene TANG
1
;
Chi Shern Bernard HO
;
Patrick Mun Yew CHAN
;
Juliana Jia Chuan CHEN
;
Mui Heng GOH
;
Ern Yu TAN
Author Information
1. Department of General Surgery, Tan Tock Seng Hospital, Singapore.
- Publication Type:Journal Article
- MeSH:
Adult;
Anti-Bacterial Agents/therapeutic use*;
Female;
Granulomatous Mastitis/therapy*;
Humans;
Quality of Life;
Retrospective Studies;
Treatment Outcome
- From:Annals of the Academy of Medicine, Singapore
2021;50(8):598-605
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:Idiopathic granulomatous mastitis (IGM) is a rare, benign, chronic breast condition that can cause repeated abscesses or mass formation in bilateral breasts. The condition can severely impact the quality of life of affected women. This study aims to evaluate effective treatment modalities, as well as understand the demographics and clinical presentation of patients with IGM.
METHODS:An 11-year retrospective review was performed of patients diagnosed with IGM from 1 January 2008 to 31 December 2018 at a tertiary breast unit.
RESULTS:A total of 77 patients were included in the study. The median age at presentation was 36 years old. IGM presented most commonly as a breast lump (98.1%). The median number of flares was 2 (1-12). Of the 77 patients, 68.8% (53) were treated with antibiotics, 50.6% (39) with steroids, and 44.2% (34) underwent surgery, in the course of their IGM treatment. Forty-five (59.2%) of the 76 patients with IGM required a multimodal treatment approach to achieve remission. There was no significant difference in the number of flares no matter the initial treatment (
CONCLUSION:IGM is a clinical diagnosis. It is a rare, relapsing breast inflammatory condition that affects young females with no superior treatment modality. Smoking is associated with higher number of flares of IGM and should be discouraged in IGM patients.
